Literature DB >> 2670258

The relationship between Klebsiella infection and ankylosing spondylitis.

A Ebringer.   

Abstract

Ankylosing spondylitis (AS) is probably produced by repeated episodes of Klebsiella-reactive arthritis, usually in HLA-B27-positive individuals. This concept is based on immunological, microbiological and serological considerations. Immunological studies based on anti-B27 tissue typing sera and anti-B27 monoclonal antibodies indicate that HLA-B27 cross-reacts with antigens found in Klebsiella, Salmonella, Shigella and Yersinia micro-organisms. Salmonella, Shigella and Yersinia gut infections are associated with a reactive arthritis that occurs predominantly in HLA-B27-positive individuals. However, microbiological studies indicate that only Klebsiella, but not Salmonella, Shigella or Yersinia, can be isolated in faecal cultures obtained from AS patients. Furthermore, serological studies involving a number of different techniques demonstrate that only antibodies against Klebsiella, but not against Salmonella, Shigella or Yersinia, can be identified in active AS patients. The evidence is sufficiently extensive to warrant long-term studies involving Klebsiella reduction in the bowel flora of AS patients, in an attempt to reduce the severity and modify the development of the disease. It would appear that Klebsiella-reactive arthritis is the precursor stage occurring in the early and active phases of AS. Only future studies can determine whether this disease will remain a taxonomic curiosity or provide guidelines for therapeutic sequelae which will be of benefit to AS patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670258     DOI: 10.1016/s0950-3579(89)80024-x

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  9 in total

Review 1.  Small intestinal mucosal protection mechanisms and their importance in rheumatology.

Authors:  S O'Mahony; A Ferguson
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

Review 2.  Mitochondrial antigens and antibodies in primary biliary cirrhosis.

Authors:  P Butler; F Valle; A K Burroughs
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  IgA antibody response to klebsiella in ankylosing spondylitis measured by immunoblotting.

Authors:  F Shodjai-Moradi; A Ebringer; I Abuljadayel
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

4.  Ankylosing spondylitis and HLA-B27: restriction fragment length polymorphism and sequencing of an HLA-B27 allele from a patient with ankylosing spondylitis.

Authors:  C M Higgins; T Lund; M E Shipley; A Ebringer; M Sadowska-Wroblewska; R K Craig
Journal:  Ann Rheum Dis       Date:  1992-07       Impact factor: 19.103

5.  Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.

Authors:  S O'Mahony; N Anderson; G Nuki; A Ferguson
Journal:  Ann Rheum Dis       Date:  1992-12       Impact factor: 19.103

Review 6.  A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment.

Authors:  Sierra N Murphy; Brandon A Nguyen; Rohin Singh; Nolan J Brown; Shane Shahrestani; Matthew T Neal; Naresh P Patel; Maziyar A Kalani
Journal:  Surg Neurol Int       Date:  2022-07-15

7.  Reactive Arthritis Resulting From Postoperative Complications of Third Molar Extraction: A Case Report.

Authors:  Lauren Maytin; Jeffrey Morrison
Journal:  Cureus       Date:  2022-08-23

8.  Surgical orodental implications in ankylosing spondylitis.

Authors:  Mohammad Mehdizadeh; Bejeh Mir A Poorsattar
Journal:  Dent Res J (Isfahan)       Date:  2012-11

Review 9.  Recent advances in ankylosing spondylitis: understanding the disease and management.

Authors:  Leticia Garcia-Montoya; Hanna Gul; Paul Emery
Journal:  F1000Res       Date:  2018-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.